by Elena Iemma | Dec 23, 2023 | Blog
FDA Request for “Integrated Summary of Immunogenicity” So much news to share! EpiVax Delivers! As promised, EpiVax 2.0 will be arriving in 2024, our 26th year, along with new team members and new plans to expand the range of services offered. Here...
by Elena Iemma | Nov 13, 2023 | Blog
This is a two-way street Hey Hey, Hallo, Hola, Ciao, Namaste, Hello, Bonjour, Konnichiwa! When do you do your “thinking” about the day? Do you do it while running? I do! And lately, I’ve been thinking about AI and Human Intelligence in vaccine development—how far...
by Elena Iemma | May 24, 2023 | Blog
AI Meets Animal Health: Smarter Vaccine Design with EpiCC™ and Human Insight The future of animal health is being shaped by powerful new technologies. At EpiVax, we’re applying AI in animal vaccine design to improve T cell epitope coverage, strengthen immune...
by Elena Iemma | Jul 22, 2022 | Events
A big thank you to everyone that came out to the pre-conference Computational Vaccinology workshop at ISV! Agenda and pictures from the day below. ISV 2022 Computational Vaccinology Conference Workshop Saturday September 17, 9-4 pm ET Delta Hotels Québec 690 Boul René...
by Elena Iemma | May 13, 2021 | News
PROVIDENCE, RI, May 13, 2021 /PRNewswire/ — EpiVax Therapeutics, Inc. (“EVT”) announces the publication “Multi‑step screening of neoantigens’ HLA and TCR‑interfaces improves prediction of survival” in Scientific Reports. This study demonstrates a superior method...
